Bulman ZP - Search Results

1

Antibiotic susceptibility patterns of viridans group streptococci isolates in the United States from 2010 to 2020.

Singh N, Poggensee L, Huang Y, Evans CT, Suda KJ, Bulman ZP. Singh N, et al. Among authors: bulman zp. JAC Antimicrob Resist. 2022 May 19;4(3):dlac049. doi: 10.1093/jacamr/dlac049. eCollection 2022 Jun. JAC Antimicrob Resist. 2022. PMID: 35599725 Free PMC article.

2

A coup d'état by NDM-producing Klebsiella pneumoniae overthrows the major bacterial population during KPC-directed therapy.

Lenhard JR, Rana AP, Wenzler E, Huang Y, Kreiswirth BN, Chen L, Bulman ZP. Lenhard JR, et al. Among authors: bulman zp. Diagn Microbiol Infect Dis. 2020 Sep;98(1):115080. doi: 10.1016/j.diagmicrobio.2020.115080. Epub 2020 May 15. Diagn Microbiol Infect Dis. 2020. PMID: 32619895 Free PMC article.

3

Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6')-Ib.

Butler DA, Rana AP, Krapp F, Patel SR, Huang Y, Ozer EA, Hauser AR, Bulman ZP. Butler DA, et al. Among authors: bulman zp. J Antimicrob Chemother. 2021 Feb 11;76(3):671-679. doi: 10.1093/jac/dkaa480. J Antimicrob Chemother. 2021. PMID: 33326561 Free PMC article.

4

Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales.

Tan X, Kim HS, Baugh K, Huang Y, Kadiyala N, Wences M, Singh N, Wenzler E, Bulman ZP. Tan X, et al. Among authors: bulman zp. Infect Drug Resist. 2021 Jan 18;14:125-142. doi: 10.2147/IDR.S246174. eCollection 2021. Infect Drug Resist. 2021. PMID: 33500635 Free PMC article. Review.

5

In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae.

Huang Y, Wu T, Perez O, Rana AP, Chen L, Kreiswirth BN, Satlin MJ, Bulman ZP. Huang Y, et al. Among authors: bulman zp. Front Microbiol. 2021 Mar 4;12:618087. doi: 10.3389/fmicb.2021.618087. eCollection 2021. Front Microbiol. 2021. PMID: 33763041 Free PMC article.

6

Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae.

Huang Y, Sokolowski K, Rana A, Singh N, Wang J, Chen K, Lang Y, Zhou J, Kadiyala N, Krapp F, Ozer EA, Hauser AR, Li J, Bulitta JB, Bulman ZP. Huang Y, et al. Among authors: bulman zp. Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0069221. doi: 10.1128/AAC.00692-21. Epub 2021 Aug 17. Antimicrob Agents Chemother. 2021. PMID: 34152820 Free PMC article.

7

Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.

Huang Y, Rana AP, Wenzler E, Ozer EA, Krapp F, Bulitta JB, Hauser AR, Bulman ZP. Huang Y, et al. Among authors: bulman zp. J Antimicrob Chemother. 2022 Feb 2;77(2):356-363. doi: 10.1093/jac/dkab381. J Antimicrob Chemother. 2022. PMID: 34668007 Free PMC article.

8

[No title available]

[No authors listed] [No authors listed] PMID: 35107156

9

[No title available]

[No authors listed] [No authors listed] PMID: 35107163

10

Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant Acinetobacter baumannii with Polymyxin-Based Combinations.

Wences M, Wolf ER, Li C, Singh N, Bah N, Tan X, Huang Y, Bulman ZP. Wences M, et al. Among authors: bulman zp. Antibiotics (Basel). 2022 Jul 16;11(7):959. doi: 10.3390/antibiotics11070959. Antibiotics (Basel). 2022. PMID: 35884213 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page